The global breast cancer market is expected to exhibit a robust 9.2% CAGR over the forecast period from 2017 to 2023, according to the latest research report from Market Research Future (MRFR). The global breast cancer market is mainly driven by the increasing awareness about the disease among the female population, the increasing prevalence of the disease among women in developed economies, and the increasing efforts being taken by major healthcare market players to come up with effective medication against cancer.
Breast cancer has taken on a special role in cancer research, as its gender specificity has increased its visibility. It is one of the most common types of cancer in the world and presents a clear and present danger in terms of dealing with the increasing economic burden of the disease. The increasing prevalence of breast cancer has driven major expenditure in the market from consumers, leading to steady development of effective cures and diagnostic techniques for the disease, driving steady growth in the market. Growing awareness among consumers about breast cancer is likely to be a key driver for the global market over the forecast period, as breast cancer has become the center of the activity of many charitable foundations due to its widespread appeal.
Get a FREE Sample with Complete TOC @ https://www.marketresearchfuture.com/sample_request/1379
Increasing efforts from major players to develop effective cures for cancer are likely to be a major driver for the global breast cancer market over the forecast period. Cancer research has emerged as a profitable avenue for market players due to its widespread prevalence, making it likely that leading players in the healthcare sector would invest in cancer research in the coming years.
Leading players in the global breast cancer market include- Bayer AG, Hospira Inc., Actavis Inc., Bristol-Myers Squibb Company, Gilead Sciences Inc., Accord Healthcare Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries, Genentech, GlaxoSmithKline, F. Hoffman-La Roche, AstraZeneca, Eli Lilly and Company, Sanofi S.A., Puma Biotechnology, Bipar Sciences, Astellas, Oncothyreon Inc., BioNumerik Pharmaceuticals, Apthera Inc., Oncogenex, Novartis AG, and Pfizer.
Research efforts are likely to be crucial for the development of the Breast Cancer Market in the coming years. In July 2019, researchers at the University of Birmingham discovered new aspects of the function of the BRCA1 gene associated with breast cancer, allowing more detailed investigations into the nature of the gene and its role in causing breast cancer. The discovery is part of a five-year research project intended to extend the information researchers possess about breast cancer and come up with genetics-based solutions to the development and progression of breast cancer.
- Breast cancer drug manufacturers
- Breast cancer drug suppliers
- Research and Development (R&D) Companies
- Government Research Laboratories
- Independent Research Laboratories
- Government and Independent Regulatory Authorities
- Market Research and Consulting Service Providers
- Medical Research Laboratories
- Academic Medical Institutes and Universities
The global breast cancer market is segmented on the basis of type into invasive ductal carcinoma, invasive lobular carcinoma, and others.
On the basis of treatment, the global breast cancer market is segmented into chemotherapy, surgery & radiation therapy, targeted therapy, biologic therapy, hormone therapy, and other. The chemotherapy segment is further segmented into antimetabolites, anthracyclines, taxanes, and alkylating agents. Target therapy is further segmented into tyrosine kinase inhibitors and monoclonal antibodies. Hormone therapy is further segmented into selective estrogen-receptor modulators (SERMs), aromatase inhibitors, and others. Chemotherapy is likely to hold the largest share in the market due to its proven efficacy in dealing with breast cancer.
On the basis of end use, the market is segmented into hospital pharmacies, private pharmacies. and others.
North America is likely to hold the largest share in the global breast cancer market over the forecast period due to the growing awareness about breast cancer and the increasing availability of advanced cures such as radiation and chemotherapy in the region. The increasing efforts being taken by female as well as male celebrities to promote breast cancer and fund research into the disease are also likely to be a key driver for the breast cancer market in North America, as this has raised the public profile of the disease and made it highly visible.
Early Diners Are Offered Free Customization- Up to 20%
Scope of Report
The report for global breast cancer market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.
Study objectives global breast cancer market
- To provide the detail information about drivers and factors restraining the market growth
- To provide the market growth map over the forecast period- 2017-2023
- To provide detailed analysis of the market structure along with forecast for the next 7 years of the various segments and sub-segments of the global breast cancer market
- To provide the graphs and analyze the market on various factors like- price analysis, supply chain analysis, porters five force analysis etc.
- To provide the trends and opportunities in global breast cancer market
- To provide historical and forecast revenue of the market segments and sub-segments with respect to main countries
- To provide the overview of key players and their strategic profiles in the market and drawing a competitive landscape for the market
Get More Information on Breast Cancer Market Research Report – Global Forecast To 2023 @ https://www.marketresearchfuture.com/reports/global-breast-cancer-market-1379
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Edibles.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar